Literature DB >> 20223711

The role of microRNA in rheumatoid arthritis and other autoimmune diseases.

Victoria Furer1, Jeffrey D Greenberg, Mukundan Attur, Steven B Abramson, Michael H Pillinger.   

Abstract

MicroRNAs (miRNAs) represent a class of non-coding RNA molecules playing pivotal roles in cellular and developmental processes. miRNAs modulate the expression of multiple target genes at the post-transcriptional level and are predicted to affect up to one-third of all human protein-encoding genes. Recently, miRNA involvement in the adaptive and innate immune systems has been recognized. Rheumatoid arthritis serves an example of a chronic inflammatory disorder in which miRNAs modulate the inflammatory process in the joints, with the potential to serve as biomarkers for both the inflammatory process and the potential for therapeutic response. This review discusses the investigations that led to miRNA discovery, miRNA biogenesis and mode of action, and the diverse roles of miRNAs in modulating the immune and inflammatory responses. We conclude with a discussion of the implications of miRNA biology in rheumatoid arthritis and other autoimmune disorders. (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20223711     DOI: 10.1016/j.clim.2010.02.005

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  46 in total

Review 1.  Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti-inflammatory drugs.

Authors:  Wolfgang Poller; Madlen Rother; Carsten Skurk; Carmen Scheibenbogen
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  microRNA Expression in Rat Apical Periodontitis Bone Lesion.

Authors:  Bo Gao; Liwei Zheng
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

3.  Assessment of the risk of polyomavirus JC reactivation in patients with immune-mediated diseases during long-term treatment with infliximab.

Authors:  Simone Giannecchini; Valeria Clausi; Alessandra Vultaggio; Lisa Macera; Fabrizio Maggi; Francesco Martelli; Alberta Azzi; Enrico Maggi; Andrea Matucci
Journal:  J Neurovirol       Date:  2012-01-27       Impact factor: 2.643

4.  Dysregulated MicroRNA Expression and Chronic Lung Allograft Rejection in Recipients With Antibodies to Donor HLA.

Authors:  Z Xu; D Nayak; W Yang; G Baskaran; S Ramachandran; N Sarma; A Aloush; E Trulock; R Hachem; G A Patterson; T Mohanakumar
Journal:  Am J Transplant       Date:  2015-02-03       Impact factor: 8.086

Review 5.  Environmental factors and hormones in the development of rheumatoid arthritis.

Authors:  Deshiré Alpízar-Rodríguez; Axel Finckh
Journal:  Semin Immunopathol       Date:  2017-04-27       Impact factor: 9.623

Review 6.  Epigenetics in Non-tumor Immune-Mediated Skin Diseases.

Authors:  M C Ovejero-Benito; E Daudén; Alejandra Reolid; E Muñoz-Aceituno; F Abad-Santos
Journal:  Mol Diagn Ther       Date:  2021-03-01       Impact factor: 4.074

7.  MicroRNA expression aberration in Chinese patients with relapsing remitting multiple sclerosis.

Authors:  Dan Yang; Wei-Zhi Wang; Xue-Mei Zhang; Hui Yue; Bing Li; Lin Lin; Jin Fu
Journal:  J Mol Neurosci       Date:  2013-11-12       Impact factor: 3.444

8.  ZFAS1 knockdown inhibits fibroblast-like synoviocyte proliferation, migration, invasion and inflammation, and promotes apoptosis via miR-3926/FSTL1 in rheumatoid arthritis.

Authors:  Qiang Wang; Peigang Chu; Xia Yu; Jun Li; Wenzheng Zhang; Mingzhi Gong
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

9.  Downregulation of lncRNA ITSN1-2 correlates with decreased disease risk and activity of rheumatoid arthritis (RA), and reduces RA fibroblast-like synoviocytes proliferation and inflammation via inhibiting NOD2/RIP2 signaling pathway.

Authors:  Tao Yue; Xiaolei Fan; Zhanming Zhang; Zhaoyi Liu; Mengru Guo; Fengmin Bai; Xumin Gong; Chenxin Gao; Lianbo Xiao
Journal:  Am J Transl Res       Date:  2019-08-15       Impact factor: 4.060

10.  The expression of Mirc1/Mir17-92 cluster in sputum samples correlates with pulmonary exacerbations in cystic fibrosis patients.

Authors:  Kathrin Krause; Benjamin T Kopp; Mia F Tazi; Kyle Caution; Kaitlin Hamilton; Asmaa Badr; Chandra Shrestha; Dmitry Tumin; Don Hayes; Frank Robledo-Avila; Luanne Hall-Stoodley; Brett G Klamer; Xiaoli Zhang; Santiago Partida-Sanchez; Narasimham L Parinandi; Stephen E Kirkby; Duaa Dakhlallah; Karen S McCoy; Estelle Cormet-Boyaka; Amal O Amer
Journal:  J Cyst Fibros       Date:  2017-12-11       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.